Latest filing published 26 Sept 2008 for DUSKA THERAPEUTICS, INC., €3,121.
Insider track record
No signal scores available.
Philip A. Sobol: trading record in brief
Philip A. Sobol has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Duska Therapeutics, Inc. and Entia Biosciences, Inc. We count 3 filings; the first trade dates from 16 August 2008 and the latest from 24 April 2015.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 28 April 2015: a share grant of €37k, in Entia Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 41 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Philip A. Sobol
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,315 shares@ US$0.45Duska Common StockSEC:0001213900-08-001872:0
- 1,961 shares@ US$0.51Duska Common StockSEC:0001213900-08-001872:1
2 of 2 declarations